Press Release
WarRin Protocol: A point-to-point anonymous privacy communication system
Dr.WarRin
Summary
This white paper provides an explanation of the WarRin protocol and related blockchain, point-to-point, network value, transport protocol, and encryption algorithms. The limited space will highlight the WRC allocation scheme and purpose of the WarRin Protocol Token, which is important for achieving the WRC’s stated objectives. This white paper is for informational purposes only and is not a promise of final implementation details. Some details may change during the development and testing phases.
1. Introduction
Traditional centralized communication systems such as WeChat,WhatsApp, FacebookMessage,Google Allo,Skype face a range of problems, including government surveillance, privacy breaches, and inadequate security, and the WarRin protocol proposes apoint-to-pointencrypted communications system that leveragesblockchain technology, combined with Double Ratc het algorithms, pre-keys, and extended X3DH handshakes. The WarRin Protocol uses The Generalized Directional Acyclic Graph and Curve25519,AES-256, and HMAC-SHA256 as the pronamor, allowing each account to have its own unique account chain, providing unlimited instant communication between points and unlimited scalability, anonymity, integrity, consistency, and asynchronousness.
2. WarRin Protocol communication system
2.1 Two types of communication
The Waring Protocol communication system divides chat channels into two types.
Two modes of communication
- General Chat mode: Using point-to-point encrypted communication, the service side has access to the key and can log in via multiple devices.
- Secret Chat mode: Encrypted communication using point-to-point can only be accessed through two specific devices.
The design combines some of the advantages of raiBlocks multi-chain construction with IOTA/Byteball DAG, which we call the Waring protocol. With improvements, we have given the WarRin protocol greater throughput and faster processing power while ensuring the security of the ledger, and network nodes can store the ledger in less space and search their communications accounts quickly in the ledger. When two users communicate, third parties contain content that neither manager can access. When a user is chatting in secret, the message contains multimedia that can be designated as a self-destruct message, and when the message is read by the user, the message is automatically destroyed within the specified time. Once the message expires, it disappears on the user’s device.
2.2 How chat history is encrypted
2.2.1 MTProto Transport Protocol
MTProto transport protocol
The WarRin communication system draws on RaiBlocks’ multi-chain structure for point-to-point communication. Each account has its own chain that records the sending and receiving behavior of the account. For example, in Figure 1, there are 7 accounts, each with 7 chain records of the account sending and receiving communications. On the graph, horizontal coordinates represent the timeline, and portrait coordinates represent the index of the account.
Transferring information from one account to another requires two transactions: one to send a communication from the sender’s transfer content, and one to receive information to add that content to the content of the receiving account. Whether in a send-side account or a receiving account, a PoW proof of work with the previous communication content Hash is required to add new communications to the account. In the account chain, poWwork proves to be an anti-spam communication tool that can be done in seconds. In a single account chain, the Hash field of the previous block is known to pre-generate the PoW required for subsequent blocks. Therefore, as long as the time between the two communications is greater than the time required to generate the PoW, the user’s transaction will be completed instantaneously.
In such a design, only the receiving end of the communication is required for settlement. The receiving end places the received communication signature on the account chain, which is called accepted communication. Once accepted, the receiving end then broadcasts the communication to the ledger of the other nodes. However, there may be situations where the receiving end is not online or is subject to a DoS attack, which prevents the receiving end from putting the receiving side communication on the account chain, which we call uncommoted transactions. The X symbol in Figure 1 represents an open transaction sent from Account 2 to Account 5.
Obviously, because only the sending and receiving sides of the communication are required to settle, such communication is very lightweight, all traffic can be transmitted in a UDP package and processed very quickly. At the same time, all communications in an account are kept in one chain, with great integrity, and the ledger can be trimmed to a minimum. Some nodes are not interested in spending resources to store the full communication history of the account; They are only interested in the current communications for each account. When an account communicates, its accumulated information is encoded, and these nodes only need to keep track of the latest blocks so that historical data can be discarded while maintaining correctness. Such communication is only possible if the sending and receiving sides trust each other and are not the final settlement of the entire network consensus. There is a security risk in the absence of trust on the sending and receiving ends, or in situations where the receiving end is attacked by DoS without the sender’s knowledge.
We have observed that although each account has a separate chain, the entire ledger can be expressed in the form of a WarRin object. As shown in Figure 2, this is represented by the WarRin astros trading on all accounts in Figure 1.
The first unit in the WarRin object is the Genesis unit, the next six cells represent the allocation of the initial token, and the other units correspond to the communication transactions between the account chains. We use the symbol a/b to represent a communication transaction, where the sender is a andthe recipient is b. The last 4/1 unit in Figure 2 is the last communication corresponding to Figure 1 – sending communication from account 4 to account 1. A transaction in Figure 1 is a confirmation of the latest block or the latest communication on the account chains of both parties to the communication, reflected in Figure 2 as a reference to the latest units of the account chains of both parties to the communication. Take unit 4/1, for example, where the latest block on account 4 was the receiving block for 2/4 trades and the newest block on account 1 was the send block for 1/5 trade. So on the DAG, the 4/1 cell refers to the 2/4 cell and the 1/5 cell.
The WarRin protocol uses triangular shrapned storage technology to crack impossible triangles in the blockchain through the shrapghine technology, with extensive node engagement and decontalination while maintaining high throughput and security:
- Complete shraping of blockchain status;
- Secure and low-cost cross-synth trading;
- Completely random witness selection;
- Flexible and efficient configuration
Complete decentralization ensures absolute security and scalability of the standard chain.
(Figures above show seven Ling-shaped objects:2/1 one;3/2 one… ）
2.2.2 Curve25519 Elliptic Curve Encryption Algorithm
Curve25519, proposed by Daniel Bernstein, is anelliptic curve algorithm for the exchange of The Montgomery Curve’s Difi Herman keys.
Montgomery Curve Curve Mathematical Expression:
Curve25519 Curve Mathematical Expression:
Curve25519 encryption algorithms are 
Generate a one-time random secret 
3. Incentives
On the basis of the WarRin agreement, by adding the incentive layer, we can effectively avoid the whole network being attacked and eliminate spam. As long as honest nodes control most of the calculations, for an attacker, the network is robust because of its simplicity of structure, and nodes need little coordination to work at the same time. They do not need to be authenticated because information is not sent to a location.
3.1 WRC Certificate
WRC issued a total of 2,500,000 pieces and continued to increment according to the WoRin gain function.
3.1.1 WoRin Gain Function
3.1.2 WoRin gain function control table
| The WoRin gain function is compared to the table | ||
| Number of layers /F | Growth factor /I | WRC circulation |
| [1,50] | 0.002 | 334918.8057 |
| [51,100] | 0.002 | 780024.2108 |
| [101,150] | 0.004 | 1177129.617 |
| [151,200] | 0.006 | 1487860.923 |
| [201,250] | 0.01 | 1722637 |
| [251,300] | 0.016 | 1894309.216 |
| [301,400] | 0.03 | 2101623.789 |
| [401,500] | 0.06 | 2217555.464 |
| [501,1000] | 0.1 | 2450712.257 |
| [1001,2000] | 0.12 | 2557457.3 |
According 
3.2 Allocation
WarRin protocol node distribution
3.2.1 Node allocation
Set the initial price 
For example, the number of tiers in which the 98th node is located is Tier 13, and the price of Tier 13 is 0.214,the tokens assigned by Tier 98 are
3.2.2 Total number of address assignments
Each node occupies one address, and the total number of 
4. The use
WRC is the native pass-through of the WarRin protocol, andWRC will assign to Genesis nodes according to the above allocation scheme, which together form the entire network, andWRC can be used in the following scenarios, including but not limited to:
Pay the network’s gas charges, i.e. for transferring money and invoking smart contracts;
System Staking tokens, used for node elections and token issues;
The capital is lent to the validator in exchange for the amount of the reward;
Voting rights for system proposals;
The means of payment for apps developed on WoRin Services;
WoRin Storage is a means of payment on the decentralization storage;
WoRin DNS domain name and WoRin WWW website means of payment;
WoRin Proxy agents hide the means of payment for body and IP addresses;
WoRin Proxy penetrates payment methods reviewed by local ISPs
……
5. Conclusions
Metcalfe’s Law states that thevalue of a network is equal to the square of the number of nodes within the network, and that the value of the network is directly related to the square of the number of connected users. That is 
References
[1] K. Birman, Reliable Distributed Systems: Technologies, Web Services and
Applications, Springer, 2005.
[2] V. Buterin, Ethereum: A next-generation smart contract and de- centralized
application platform, https://github.com/ethereum/wiki/wiki/White-Paper, 2013.
[3] M. Ben-Or, B. Kelmer, T. Rabin, Asynchronous secure computa- tions with
optimal resilience, in Proceedings of the thirteenth annual ACM symposium on
Principles of distributed computing, p. 183–192. ACM, 1994.
[4] M. Castro, B. Liskov, et al., Practical byzantine fault tolerance, Proceedings of the
Third Symposium on Operating Systems Design and Implementation (1999), p. 173–
186, available at http://pmg.csail.mit.edu/papers/osdi99.pdf.
[5] EOS. IO, EOS. IO technical white paper,
https://github.com/EOSIO/Documentation/blob/master/TechnicalWhitePaper.md,
2017.
[6] D. Goldschlag, M. Reed, P. Syverson, Onion Routing for Anony- mous and
Private Internet Connections, Communications of the ACM, 42, num. 2 (1999),
http://www.onion-router.net/Publications/CACM-1999.pdf.
[7] L. Lamport, R. Shostak, M. Pease, The byzantine generals problem, ACM
Transactions on Programming Languages and Systems, 4/3 (1982), p. 382–401.
[8] S. Larimer, The history of BitShares,
https://docs.bitshares.org/bitshares/history.html, 2013.
[9] M. Luby, A. Shokrollahi, et al., RaptorQ forward error correction scheme for
object delivery, IETF RFC 6330, https://tools.ietf.org/html/rfc6330, 2011.
[10] P. Maymounkov, D. Mazières, Kademlia: A peer-to-peer infor- mation system
based on the XOR metric, in IPTPS ’01 revised pa- pers from the First International
Workshop on Peer-to-Peer Systems, p. 53–65, available at
http://pdos.csail.mit.edu/~petar/papers/ maymounkov-kademlia-lncs.pdf, 2002.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Ryan Bueter Shares a Powerful Story of Music, Addiction, Cancer, Survival, Faith, and Finding Purpose
New York, United States, 23rd Sep 2026 – Professional musician, entertainer, businessman, and author Ryan Bueter shares an intensely personal journey through addiction, sobriety, cancer treatment, faith, and recovery in his new book, Throat Cancer Diary: One Gen Xer’s Story of Rock ’n Roll, Addiction, Cancer, and God.
At 3:30 p.m. on March 28, 2025, Bueter opened an email containing words that would abruptly divide his life into before and after:
“Squamous cell carcinoma positive for p16.”
Only ten days earlier, he had undergone surgery to remove a tumor from the right side of his neck. Expecting to discuss the results with his doctor the following week, Bueter instead received the diagnosis unexpectedly through his inbox on a Friday afternoon.
For anyone, a cancer diagnosis can bring fear and uncertainty. For Bueter, a professional musician whose life and career had been shaped by performance, one question carried particular weight:
What would cancer do to his voice?
That question becomes one of the emotional threads running through Throat Cancer Diary, but Bueter’s story begins long before his diagnosis.
A Life Shaped by Music, Addiction, and Reinvention
Growing up in Dublin, Ohio, Bueter discovered music as a way to quiet the insecurities he carried inside. His journey took him from playing drums as a child to pursuing the dream of becoming a rock star in Hollywood, performing in bands, and ultimately building a new career in the world of dueling pianos.
Behind the performances, however, was another struggle.
Bueter writes candidly about alcohol, drugs, insecurity, the need for validation, destructive behavior, and his eventual journey toward sobriety. Rather than separating these experiences from his later battle with cancer, Throat Cancer Diary examines how addiction, recovery, music, relationships, business, faith, and illness became interconnected chapters of one life.
Then cancer changed the rhythm again.
Surgery was followed by radiation and the difficult realities of treatment: the restrictive treatment mask, pain, exhaustion, loss of taste, difficulty swallowing, fear, and uncertainty.
For a man whose identity had been intertwined with music, the possibility of losing his voice represented more than a professional concern. It threatened something that had helped define him since childhood.
When the Voice Is More Than a Voice
Throughout treatment, Bueter continued returning to a question that gradually transformed the meaning of his experience:
How can this help someone else?
That question lies at the heart of Throat Cancer Diary.
The book does not present cancer as an inspirational obstacle that simply disappears once treatment ends. Instead, Bueter acknowledges the uncertainty of recovery and the reality that surviving treatment does not erase what a patient and their loved ones have experienced.
Yet amid that uncertainty comes one of the book’s defining moments.
Bueter sings again.
His voice is different. Recovery remains unfinished. The future still contains questions.
But his voice is there.
It stayed.
That moment becomes symbolic of the book’s larger message: people may not control what enters their lives, but they can decide what they do with the experience that follows.
“This book was written to be useful,” Bueter explains through the story’s central purpose. His experience is presented not simply as a record of what happened, but as something that may help another person confronting illness, addiction, fear, or an unexpected change in life.
A Story for Patients, Families, Musicians, and Anyone Facing an Unexpected Chapter
Throat Cancer Diary reaches beyond a traditional cancer memoir. It explores the life surrounding the diagnosis and the experiences that shaped the person confronting it.
Readers encounter childhood insecurity, rock ’n roll aspirations, addiction and sobriety, entrepreneurship, friendships, family, faith, treatment, recovery, and the people who supported Bueter when he could no longer carry everything himself.
The book may particularly resonate with people who have recently received a cancer diagnosis, musicians concerned about illness affecting their art, individuals navigating addiction or sobriety, family members trying to understand a loved one’s treatment experience, and anyone attempting to find meaning after life changes without warning.
Rather than promising a perfectly resolved ending, Bueter offers something more grounded: the perspective of someone still moving forward.
More Than a Cancer Diary
The title may center on cancer, but the story asks broader questions about identity and purpose.
What happens when the career, talent, routine, or ability that has helped define a person is suddenly threatened?
What remains when circumstances force someone to reconsider who they are?
And can one of life’s most difficult chapters eventually become useful to someone else?
For Bueter, music remains part of the answer.
So do sobriety, faith, family, friendship, and the decision to tell the story.
Throat Cancer Diary ultimately chronicles not only a fight against disease, but a life repeatedly forced to change—and one man’s continuing effort to turn those changes into purpose.
The voice is different. The journey continues. But the voice stayed.
About the Author
Ryan Bueter is a professional musician, entertainer, businessman, and author whose life has been deeply shaped by music. From childhood drumming and pursuing rock ’n roll ambitions to performing in bands and developing a career in dueling pianos, music has remained a defining force throughout his journey.
His experiences with addiction, sobriety, entrepreneurship, cancer, treatment, recovery, family, friendship, and faith form the foundation of Throat Cancer Diary. By documenting his experiences candidly, Bueter hopes his story can provide perspective and encouragement to people confronting their own unexpected battles.
Book Information
Title: Throat Cancer Diary
Subtitle: One Gen Xer’s Story of Rock ’n Roll, Addiction, Cancer, and God
Author: Ryan Bueter
Themes: Memoir | Cancer | Music | Addiction & Recovery | Faith | Survival
Language: English
View Throat Cancer Diary on Amazon
Media Contact
Organization: USA Publishing Hub
Contact Person: Steve Harper
Website: https://usapublishinghub.com/
Email: Send Email
Contact Number: +12677145850
Address: 353 Lexington Avenue
Address 2: 6th Floor Suite #603-PMB
City: New York
State: New York
Country: United States
Release id: 49350
The post Ryan Bueter Shares a Powerful Story of Music, Addiction, Cancer, Survival, Faith, and Finding Purpose appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Dr. F. Eugene McGee Shares Three Decades of Urban Education Experience in New Classroom Guide
Educating the Urban Student focuses on relationships, student behavior, social-emotional learning, and practical classroom strategies
New York, New York, United States, 23rd Sep 2026 – Dr. F. Eugene McGee draws on three decades of urban education experience to create Educating the Urban Student: A Teacher’s Quick Guide to Strategies and Tactics for the Classroom, a practical guide for teachers and school leaders.
McGee’s career has included roles as a substitute teacher, paraprofessional, classroom teacher, dean of students, assistant principal, principal, and central administrator, including serving as the Director of Extended Day Programs. The book reflects lessons learned through firsthand experience in classrooms, parent meetings, school hallways, and administrative offices rather than theory alone.
A central theme of the book is understanding the context behind student behavior. McGee encourages educators to maintain clear expectations while also recognizing that academic frustration, family responsibilities, emotional stress, and circumstances outside school may influence how students respond in the classroom.
The book also cautions teachers against making assumptions about students or their families. A parent’s absence from a conference, for example, may be influenced by work schedules, transportation, childcare, or other barriers rather than a lack of interest in a child’s education.
Another major focus is relationship-building. McGee emphasizes the importance of learning students’ names, interests, strengths, and academic needs while establishing structure from the beginning of the school year.
The guide also explores social-emotional learning and data-informed instruction. McGee describes practices such as greeting students at the classroom door, observing changes in behavior, and using assessments, classroom observations, and student work to make more informed instructional decisions.
Organized around the progression of a school year, Educating the Urban Student covers the opening weeks of school, relationship-building, home life, social-emotional learning, data-informed instruction, and professional growth.
McGee has also recently defended his doctoral dissertation, adding another stage to a career shaped by classroom experience, school leadership and continued professional development. He plans to continue the discussion in a second volume focused on practical guidance for administrators.
At its core, the book encourages educators to look beyond immediate behavior, understand the students in front of them, and combine empathy, structure, and informed decision-making in the classroom.
About the Author
Dr. F. Eugene McGee is an educator and school leader with three decades of experience working in urban education. His career has included service as a substitute teacher, paraprofessional, classroom teacher, dean of students, assistant principal, principal, and central administrator, including serving as the Director of Extended Day Programs. His professional experience across multiple levels of the school system has shaped his practical approach to classroom relationships, student support, instructional leadership, and data-informed decision-making.
McGee has also led professional development sessions for educators and recently defended his doctoral dissertation. Through Educating the Urban Student, he brings together lessons from his classroom and leadership experiences to provide educators with practical strategies they can adapt to their own students and school communities.
Media Contact
Organization: USA Publishing Hub
Contact Person: Steve Harper
Website: https://usapublishinghub.com/
Email: Send Email
Contact Number: +12677145850
Address: 353 Lexington Avenue
Address 2: 6th Floor Suite #603-PMB
City: New York
State: New York
Country: United States
Release id: 49332
The post Dr. F. Eugene McGee Shares Three Decades of Urban Education Experience in New Classroom Guide appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Ashburn, Virginia, September 22nd, 2026, FinanceWire
– First-Ever Fast Track Designation Granted for a Peeling Skin Syndrome Therapy
– Second Fast Track Designation Granted to QRX003, in Addition to Netherton Syndrome
– Fast Track Designation Facilitates Development and Expedites Regulatory Review of Therapies Addressing Serious Conditions with Significant Unmet Medical Need
– Follows July 2026 FDA Clearance of the First-Ever IND Submitted for Peeling Skin Syndrome
– Phase 2/3 Study Expected to Initiate in 2H 2026, Enrolling up to 12 Pediatric and Adult Patients in the U.S. and Europe
– Peeling Skin Syndrome Currently Has No Approved Treatment
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to QRX003 for the treatment of Peeling Skin Syndrome (PSS). QRX003 is an investigational topical serine protease inhibitor lotion. Peeling Skin Syndrome is a rare genetic skin disease for which there is currently no approved treatment.
Key Facts
- Fast Track Designation applies to QRX003 for the treatment of Peeling Skin Syndrome.
- This is the first ever Fast Track Designation granted for a Peeling Skin Syndrome therapy.
- Peeling Skin Syndrome is the second indication for which QRX003 has received Fast Track Designation. The FDA granted Fast Track Designation to QRX003 lotion (4%) for the treatment of Netherton Syndrome on March 11, 2026.
- The designation follows FDA clearance in July 2026 of Quoin’s Investigational New Drug (IND) application for QRX003 in Peeling Skin Syndrome. Quoin submitted that IND on June 2, 2026, and it was the first IND ever submitted to the FDA for the disease.
- Quoin expects to initiate a Phase 2/3 clinical study of QRX003 in Peeling Skin Syndrome in the second half of 2026.
- The IND submission was supported by clinical observations from an ongoing investigator-led pediatric study in a single subject. Significant improvements in skin appearance along with positive changes in pruritus and a number of quality-of-life measures have been recorded. Treatment is ongoing and has continued for more than 15 months, with no adverse events reported.
- There is currently no approved treatment for Peeling Skin Syndrome.
“This is an important regulatory milestone for QRX003 and for a community that today has no approved treatment,” said Dr. Michael Myers, CEO and Co-Founder of Quoin Pharmaceuticals. “Quoin submitted the first IND ever filed with the FDA for Peeling Skin Syndrome, that IND was cleared in July, and QRX003 has now been granted Fast Track Designation for the disease. We expect to initiate our Phase 2/3 study in the second half of 2026, and we believe Fast Track status will allow us to work closely with the agency as we advance the first company-sponsored clinical study in this disease.”
Peeling Skin Syndrome Development Program
The planned Phase 2/3 study is expected to enroll up to 12 pediatric and adult patients with Peeling Skin Syndrome in the United States and Europe. In the study, QRX003 will be applied twice-daily to greater than 80% of patients’ body surface area (BSA) over a 48-week period, with an interim data review at 24 weeks. Quoin is targeting approval of QRX003 as a potential treatment for Peeling Skin Syndrome in 2028.
The IND submission was supported by clinical observations from an ongoing investigator-led pediatric study. The subject has achieved improvements across key objective severity endpoints, including the Modified Ichthyosis Area Severity Index (M-IASI), Investigator’s Global Assessment (IGA) as well as pruritus and a pediatric dermatology-specific quality-of-life measure (CDLQI). Treatment is ongoing, and after continued dosing with QRX003 for over 15 months, no adverse events have been reported.
About Fast Track Designation
The FDA’s Fast Track program is designed to facilitate the development and expedite the review of drugs that treat serious conditions and fill an unmet medical need. A therapy granted Fast Track Designation may benefit from more frequent interactions with the FDA, eligibility for rolling review of regulatory submissions, and potential qualification for Accelerated Approval and Priority Review, if relevant criteria are met.
About Peeling Skin Syndrome (PSS)
Generalized inflammatory peeling skin syndrome (PSS) is a rare autosomal recessive genodermatosis caused by loss-of-function disease-causing variants of the corneodesmosin gene (CDSN), resulting in excessive shedding of the superficial layers of the epidermis. Patients generally suffer from a variety of conditions including severe pain and chronic pruritus (itch). There is currently no approved treatment for PSS.
About QRX003
QRX003 is an investigational topical serine protease inhibitor lotion in late-stage development for Netherton Syndrome and other orphan skin diseases. QRX003 has been granted Orphan Drug, Rare Pediatric Disease, and Fast Track designations by the U.S. Food and Drug Administration, and Orphan Drug Designation in the European Union and Japan for Netherton Syndrome. QRX003 has also been granted Rare Pediatric Disease and Fast Track Designation by the FDA for Peeling Skin Syndrome. QRX003 lotion (4%) is currently being evaluated in Phase 2/3 whole-body clinical trials in patients with Netherton Syndrome. Quoin expects to initiate a Phase 2/3 clinical study of QRX003 in Peeling Skin Syndrome in the second half of 2026.
About Quoin Pharmaceuticals Ltd
Quoin Pharmaceuticals Ltd. is a late clinical-stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities, and care teams. Quoin’s innovative pipeline is focused on two key platform products, QRX003 and QRX009, that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Pachyonychia Congenita, Gorlin Syndrome and Tuberous Sclerosis Complex, Microcystic Lymphatic Malformations, Venous Malformations, Angiofibromas and others.
For more information, visit: www.quoinpharma.com or LinkedIn for updates.
Forward-Looking Statements
The Company cautions that statements in this press release that are not descriptions of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words referencing future events or circumstances, such as “expect,” “intend,” “hope,” “plan,” “potential,” “anticipate,” “look forward,” “believe,” “may,” and “will,” among others. This press release contains forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs, or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to: Fast Track Designation facilitating development and expediting regulatory review of therapies addressing serious conditions with significant unmet medical need; plans to initiate a Phase 2/3 clinical study of QRX003 in Peeling Skin Syndrome in the second half of 2026; Fast Track status allowing Quoin to work closely with the FDA to advance the first company-sponsored clinical study in Peeling Skin Syndrome; the study expecting to enroll up to 12 pediatric and adult patients with Peeling Skin Syndrome in the United States and Europe; QRX003 expected to be applied twice-daily to greater than 80% of a patients’ body surface area over a 48-week period, with an interim data review at 24 weeks; targeting approval of QRX003 as a potential treatment for Peeling Skin Syndrome in 2028; therapies granted Fast Track Designation benefiting from more frequent interactions with the FDA, eligibility for rolling review of regulatory submissions, and potential qualification for Accelerated Approval and Priority Review, if relevant criteria are met; and Quoin’s products in development collectively having the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Pachyonychia Congenita, Gorlin Syndrome, Tuberous Sclerosis Complex, Microcystic Lymphatic Malformations, Venous Malformations, Angiofibroma and others. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon the Company’s current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties including, but not limited to, the Company’s ability to pursue its regulatory strategy; the Company’s ability to obtain regulatory approvals for commercialization of product candidates or to comply with ongoing regulatory requirements; the Company’s ability to complete clinical trials on time and achieve desired results and benefits as expected; and other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and in other filings the Company has made and may make with the SEC in the future. One should not place undue reliance on these forward-looking statements, which speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as may be required by law.
Contacts
Jeff Ramson
jramson@pcgadvisory.com
Michael Myers
mmyers@quoinpharma.com
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Ryan Bueter Shares a Powerful Story of Music, Addiction, Cancer, Survival, Faith, and Finding Purpose
Dr. F. Eugene McGee Shares Three Decades of Urban Education Experience in New Classroom Guide
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release5 days ago
RGMBS 2026 Life Sciences Innovation Forum Draws More Than USD 120 Million in Investor Interest as 23 Global Biotech Innovators Pitch in Riyadh
-
Press Release4 days ago
AJ Auto Expands Specialist Jaguar Land Rover Key Replacement Services for Drivers Facing Lost, Damaged and Replacement Key Problems
-
Press Release5 days ago
RELABEL HAIR MyeongDong Emerges as Seoul, Korea’s New Creative Beauty Destination for Global Travelers
-
Press Release5 days ago
Oceanic Iron Ore CEO Chris Batalha Gives Overview of Ungava Bay Assets
-
Press Release4 days ago
From Boardroom to Race Day: COOFANDY and Global Brand Ambassador Christopher Bell Redefine Modern Men’s Wardrobe
-
Press Release5 days ago
Cove Named 2026 IABE Regional Excellence Award Winner for Utah
-
Press Release4 days ago
Online Mastery Launches Free Platform and Weekly Playbook to Help Americans Build Profitable Online Businesses From Scratch
-
Press Release5 days ago
Wayne Walton Commits to a Student-First Standard for High School Athletic Departments